Literature DB >> 21119930

Variability in melanoma metalloproteinase expression profiling.

Orsi Giricz1, Janelle L Lauer, Gregg B Fields.   

Abstract

The proteolytic activities of a disintegrin and metalloproteinase (ADAM); a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS), and matrix metalloproteinase (MMP) families play important roles in normal and multiple pathological conditions. These metalloproteases have potential roles in the degradation of the ECM and in the processing of bioactive molecules. In the present study, RNA was isolated from multiple normal fibroblast and metastatic melanoma cell lines, as well as the isogenic normal tissue and tumor samples, and the gene expression levels of six ADAMs, eight MMPs, and four ADAMTSs were analyzed by real-time PCR. This approach allowed for detected changes in mRNA expression of the individual metalloproteinase genes to be compared between normal and metastatic states and also between tissue and cultured cells. Increased gene expression of several ADAM and MMP family members (MMP1, MMP8, MMP15, and ADAM15) occurred in melanoma tissue and was replicated in tissue cultures. In general, the level of ADAM and MMP mRNA expression was several-fold higher in cultured cells compared with the isogenic tissue from which they were derived. Passage-dependent expression patterns were observed for MMP8 and MMP9 in in-house-derived metastatic melanoma cell lines. This reiterates earlier suggestions that experiments using cells that have been maintained in culture should be interpreted with great care.

Entities:  

Keywords:  ADAM; MMP; tissue

Mesh:

Substances:

Year:  2010        PMID: 21119930      PMCID: PMC2977965     

Source DB:  PubMed          Journal:  J Biomol Tech        ISSN: 1524-0215


  87 in total

Review 1.  The AP-1 site and MMP gene regulation: what is all the fuss about?

Authors:  U Benbow; C E Brinckerhoff
Journal:  Matrix Biol       Date:  1997-03       Impact factor: 11.583

Review 2.  Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases.

Authors:  P Borden; R A Heller
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1997       Impact factor: 1.807

Review 3.  Matrix metalloproteinases in human melanoma.

Authors:  U B Hofmann; J R Westphal; G N Van Muijen; D J Ruiter
Journal:  J Invest Dermatol       Date:  2000-09       Impact factor: 8.551

4.  Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.

Authors:  H Ueno; H Nakamura; M Inoue; K Imai; M Noguchi; H Sato; M Seiki; Y Okada
Journal:  Cancer Res       Date:  1997-05-15       Impact factor: 12.701

5.  Increased expression of ADAM family members in human breast cancer and breast cancer cell lines.

Authors:  Uwe Lendeckel; Jana Kohl; Marco Arndt; Stacy Carl-McGrath; Hans Donat; Christoph Röcken
Journal:  J Cancer Res Clin Oncol       Date:  2004-09-30       Impact factor: 4.553

6.  The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.

Authors:  Stacy Carl-McGrath; Uwe Lendeckel; Matthias Ebert; Albert Roessner; Christoph Röcken
Journal:  Int J Oncol       Date:  2005-01       Impact factor: 5.650

7.  Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.

Authors:  M Nakada; H Nakamura; E Ikeda; N Fujimoto; J Yamashita; H Sato; M Seiki; Y Okada
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

8.  Stromal expression of MMP-13 is required for melanoma invasion and metastasis.

Authors:  Paola Zigrino; Isolde Kuhn; Tobias Bäuerle; Jan Zamek; Jay W Fox; Susanne Neumann; Alexander Licht; Marina Schorpp-Kistner; Peter Angel; Cornelia Mauch
Journal:  J Invest Dermatol       Date:  2009-06-11       Impact factor: 8.551

9.  Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma.

Authors:  A Väisänen; M Kallioinen; P J Taskinen; T Turpeenniemi-Hujanen
Journal:  J Pathol       Date:  1998-09       Impact factor: 7.996

10.  Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding.

Authors:  Georgina S Butler; Richard A Dean; Eric M Tam; Christopher M Overall
Journal:  Mol Cell Biol       Date:  2008-05-27       Impact factor: 4.272

View more
  8 in total

1.  Collagen XVII is expressed in malignant but not in benign melanocytic tumors and it can mediate antibody induced melanoma apoptosis.

Authors:  T Krenacs; G Kiszner; E Stelkovics; P Balla; I Teleki; I Nemeth; E Varga; I Korom; T Barbai; V Plotar; J Timar; E Raso
Journal:  Histochem Cell Biol       Date:  2012-06-12       Impact factor: 4.304

2.  Roles of different IRES-dependent FGF2 isoforms in the acquisition of the major aggressive features of human metastatic melanoma.

Authors:  Elena Andreucci; Francesca Bianchini; Alessio Biagioni; Mario Del Rosso; Laura Papucci; Nicola Schiavone; Lucia Magnelli
Journal:  J Mol Med (Berl)       Date:  2016-08-24       Impact factor: 4.599

3.  Generation and characterization of rendomab-B1, a monoclonal antibody displaying potent and specific antagonism of the human endothelin B receptor.

Authors:  Bertrand Allard; Anne Wijkhuisen; Aurélie Borrull; Frédérique Deshayes; Fabienne Priam; Patricia Lamourette; Frédéric Ducancel; Didier Boquet; Jean-Yves Couraud
Journal:  MAbs       Date:  2012-12-05       Impact factor: 5.857

4.  Tpl2 knockout keratinocytes have increased biomarkers for invasion and metastasis.

Authors:  Kathleen L Decicco-Skinner; Sarah A Jung; Tracy Tabib; J Curtis Gwilliam; Hepzibha Alexander; Sarah E Goodheart; Anand S Merchant; Mengge Shan; Caroline Garber; Jonathan S Wiest
Journal:  Carcinogenesis       Date:  2013-09-25       Impact factor: 4.944

5.  Matrix metalloprotease-1a promotes tumorigenesis and metastasis.

Authors:  Caitlin J Foley; Chi Luo; Katie O'Callaghan; Philip W Hinds; Lidija Covic; Athan Kuliopulos
Journal:  J Biol Chem       Date:  2012-05-09       Impact factor: 5.157

6.  Transcriptome Analysis of Canine Cutaneous Melanoma and Melanocytoma Reveals a Modulation of Genes Regulating Extracellular Matrix Metabolism and Cell Cycle.

Authors:  Chiara Brachelente; Katia Cappelli; Stefano Capomaccio; Ilaria Porcellato; Serenella Silvestri; Laura Bongiovanni; Raffaella De Maria; Andrea Verini Supplizi; Luca Mechelli; Monica Sforna
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

7.  Strong Dependence between Tryptophan-Related Fluorescence of Urine and Malignant Melanoma.

Authors:  Anna Birková; Marcela Valko-Rokytovská; Beáta Hubková; Marianna Zábavníková; Mária Mareková
Journal:  Int J Mol Sci       Date:  2021-02-13       Impact factor: 5.923

Review 8.  Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma.

Authors:  Salvatore Napoli; Chiara Scuderi; Giuseppe Gattuso; Virginia Di Bella; Saverio Candido; Maria Sofia Basile; Massimo Libra; Luca Falzone
Journal:  Cells       Date:  2020-05-07       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.